Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Invensys To Return About GBP 625 Mln Cash To Shareholders - Quick Facts

Invensys Plc. (ISYS.L, IVNYY.PK) confirmed its intention to return about 625 million pounds of the cash proceeds received from the company's recent disposal of its Rail Division to Siemens (SI: Quote) through a return of 76.7 pence per Existing Ordinary Share to Shareholders on the register as at 6.00 p.m. on 11 June 2013.

The company said that the Return of Cash has been structured to allow Shareholders, subject to applicable overseas restrictions, to elect to receive their proceeds as immediate income, immediate capital, deferred capital or any combination of the three.

The company said it proposes a proportional consolidation of its ordinary share capital in order to maintain the market price for Ordinary Shares at approximately the same level as prevailed immediately prior to the implementation of the Return of Cash. Accordingly, Shareholders will receive 4 New Ordinary Shares for every 5 Existing Ordinary Shares held at the Record Time. The effect of this will be to reduce the number of Existing Ordinary Shares in issue to reflect the return of 76.7 pence per Existing Ordinary Share to Shareholders under the Return of Cash.

However, the company said the shareholders will own the same proportion of the Company as they did beforehand, subject to fractional entitlements and to any dilution as a result of issues of New Ordinary Shares to the Company's employee benefit trusts.

In addition, the company has arranged for facilities to be made available to holders of 1,200 or fewer Existing Ordinary Shares at the Record Time with a registered address in the UK, any other EEA Country or Australia. The Nil Cost Dealing Facilities will give Small Shareholders the opportunity to sell all (but not some) of their New Ordinary Shares free of dealing costs and commissions, which are typically disproportionate for a holding of Ordinary Shares of this size.

On 15 May 2013 the Board recommended a final dividend for the full year ended 31 March 2013 of 2.85 pence per Existing Ordinary Share, amounting to 23 million pounds in aggregate, such final dividend being subject to approval of Shareholders at the Company's Annual General Meeting.

If the Share Capital Consolidation is approved by Shareholders at the General Meeting, the Board has recommended that the aggregate amount of the final dividend will remain 23 million pounds but will be paid on the New Ordinary Shares resulting from the Share Capital Consolidation. As a result, the final dividend (if approved) will increase to 3.57 pence per New Ordinary Share.

Register
To receive FREE breaking news email alerts for Invensys Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The U.K. economy grew more than estimated in the second quarter and the current account deficit widened from the first quarter, the Office for National Statistics said Tuesday. Gross domestic product grew 0.9 percent sequentially, up from the prior estimate of 0.8 percent. The annual growth was confirmed at 3.2 percent. Eurozone inflation slowed in September, as expected, to the lowest since late 2009 and the unemployment rate remained stable at a double digit level in August putting pressure on the European Central Bank to launch a full-blown easing. Inflation came in at 0.3 percent, slower than August's 0.4 percent. This was the lowest since October 2009, when prices fell 0.1 percent. Chinese authorities on Tuesday eased some rules for mortgages for buying a second home, in a bid to boost the housing market. The People's Bank of China and the China Banking Regulatory Commission said in a joint statement that buyers who already own one apartment, but have paid off the mortgage...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.